Background: Schizophrenia is a mental illness with symptoms like delusions and hallucinations. A recent study concluded that individuals with vitamin D deficiency are twice more likely to have schizophrenia than optimum level vitamin D people. Objective: To measure schizophrenic patients` serum vitamin D concentration and compare it to healthy controls(non schizophrenics), and to investigate the relationship between serum schizophrenia and related potential risk factors. Subjects and Methods: Twenty patients with schizophrenia were recruited and compared to 20 controls with no major psychopathology using age and sex matched case control study. The SCID-1(semi-structured interview for making major DSM-IV Axis 1 diagnoses), was administered and the blood samples were withdrawn after patient consent on the same day. Results: Schizophrenic patients showed a significantly lower mean vitamin D level (14.8±4.5 IU) compared to control group (19.6±3.3 IU) (P<0.001). Higher vitamin D level participants were nearly 80% less likely to have schizophrenia compared to low level ones. Being older and female were 80%and 40% less likely to have schizophrenia respectively. Individuals with large body mass index were 1.2 times more likely to have schizophrenia compared to normal body weight. Smokers were 10% less likely to be schizophrenic compared to non-smoker participants. Conclusions: Patients with schizophrenia showed lower serum vitamin D level compared to healthy controls. Further studies are needed to explore the role of vitamin D in the pathogenesis of schizophrenia. Keywords:Vitamin D and Schizophrenia, low vitamin D as a risk of schizophrenia, role of vitamin D in Schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.